| The Case for Dual Renin-Angiotensin System Inhibition - Archives of Internal Medicine |
|
|
Archives of Internal MedicineKu et al 1 cite the findings of the Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High Vascular Risk (ONTARGET) trial 2 in arguing ... read more |